Plague vaccine research and development

Abstract excerpt

1. Summary, 606 2. Introduction, 606 3. A recombinant subunit vaccine for plague, 606 4. Production of the recombinant F1 + V vaccine, 606 5. Vaccine efficacy, 607 6. Surrogate marker of protective efficacy, 607 7. Conclusions, 607 8. References, 607 A fully recombinant subunit vaccine is described which provides enhanced protection against bubonic plague and a new prophylactic against the pneumonic form of the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacillus and Francisella bacterial research
• Share to Yersinia bacterium, plague, ectoparasites research
• Share to Zoonotic diseases and public health